Literature DB >> 27678208

New test of odor pleasantness in Parkinson's disease.

Kristyna Pospichalova, Jan Vodicka, Ales Kopal.   

Abstract

The New Test of Odor Pleasantness (NTOP) evaluates the hedonicity of olfactory stimulants. The aim of this study was to compare results of the NTOP, the Sniffin' Sticks test, and the Odorized Marker Test (OMT) in patients with Parkinson's disease (PD). The study sample comprised 30 PD patients (mean age 71±7.36 years) and the control group made up of 31 non-PD subjects (mean age 68±12.39 years). Sociodemographic data, medical history and tests of cognitive function were investigated. Olfaction was evaluated using the NTOP, Sniffin' Sticks test and OMT. The PD patients, compared with the control group, recorded significantly lower scores on all three tests: NTOP (p=0.00), Sniffin' Sticks (p=0.02), OMT (p=0.00). The NTOP was the test preferred by 55% of the subjects. This preference was more marked in the PD group. This study shows that the NTOP is a valuable method within the complex array of olfactory screening tools used in PD.

Entities:  

Mesh:

Year:  2016        PMID: 27678208      PMCID: PMC5115229          DOI: 10.11138/fneur/2016.31.3.149

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  25 in total

Review 1.  The visual system in Parkinson's disease.

Authors:  I Bodis-Wollner
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1990

2.  Olfactory loss may be a first sign of idiopathic Parkinson's disease.

Authors:  Antje Haehner; Thomas Hummel; Cornelia Hummel; Ulrike Sommer; Susann Junghanns; Heinz Reichmann
Journal:  Mov Disord       Date:  2007-04-30       Impact factor: 10.338

3.  Somatosensory, motor and special visual evoked potentials to single and double stimulation in "Parkinson's disease" an early diagnostic test?

Authors:  J Jörg; H Gerhard
Journal:  J Neural Transm Suppl       Date:  1987

4.  Olfactory impairment in Parkinson's disease.

Authors:  C D Ward; W A Hess; D B Calne
Journal:  Neurology       Date:  1983-07       Impact factor: 9.910

5.  Brief evaluation of pleasantness of olfactory and trigeminal stimulants.

Authors:  Jan Vodicka; Milan Meloun; Lucie Príhodová
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-09

Review 6.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; Jeroen G Lijmer; David Moher; Drummond Rennie; Henrica C W de Vet
Journal:  BMJ       Date:  2003-01-04

7.  Functional imaging of the cerebral olfactory system in patients with Parkinson's disease.

Authors:  B Westermann; E Wattendorf; U Schwerdtfeger; A Husner; P Fuhr; O Gratzl; T Hummel; D Bilecen; A Welge-Lüssen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05-22       Impact factor: 10.154

8.  Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Authors:  R L Doty; D A Deems; S Stellar
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

9.  Evidence for deficiencies in perceptual and semantic olfactory processes in Parkinson's disease.

Authors:  Julie Hudry; Stéphane Thobois; Emmanuel Broussolle; Patrice Adeleine; Jean-Pierre Royet
Journal:  Chem Senses       Date:  2003-07       Impact factor: 3.160

10.  Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease.

Authors:  Isidro Ferrer
Journal:  Parkinsons Dis       Date:  2011-02-17
View more
  2 in total

1.  Pleasantness and trigeminal sensations as salient dimensions in organizing the semantic and physiological spaces of odors.

Authors:  C C Licon; C Manesse; M Dantec; A Fournel; M Bensafi
Journal:  Sci Rep       Date:  2018-05-31       Impact factor: 4.379

2.  Assessment of odor hedonic perception: the Sniffin' sticks parosmia test (SSParoT).

Authors:  David T Liu; Antje Welge-Lüssen; Gerold Besser; Christian A Mueller; Bertold Renner
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.